The global infectious diseases in vitro diagnostics market size is estimated to reach USD 26.5 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.2% over the forecast period. Growing geriatric population and increased consumer awareness regarding the advantages of in-vitro diagnostics (IVD) tests are anticipated to drive the market growth.
With
advancements in in-vitro diagnostics, a subsequent demand has been witnessed
for improved diagnosis in terms of precision, accuracy, speed, and specificity.
New-age diagnostics are leading to a marked decline in sales of old products
that are not at par. Moreover, although most diagnostics are specific to an
application, upcoming diagnostic products would be able to test and confirm
multiple related diseases, thus saving time and money. Technological
advancements in the field of biomarkers are also a significant driver for this
market.
Presence
of various e-commerce sites offering diagnostic kits, especially Point of Care
(PoC) devices, is expected to drive the sales of the products through this
sales channel. Several manufacturers are selling IVD kits via e-commerce
channels that provide the added benefits of discounts, warranty, and prompt
customer service. In addition, some e-commerce sites offer insurance on these
products which also provide an additional advantage to the buyers.
Moreover,
the regulatory and reimbursement landscape is continually evolving to adapt to
the fast-paced research progress in this sector. Proactive initiatives by
public and private organizations to raise consumer awareness about infectious
diseases and treatment modalities are expected to drive the market growth in
the coming years.
Full Research Report On Infectious Diseases In Vitro Diagnostics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/ivd-infectious-disease-market
Further key
findings from the report suggest:
- Technological advancements
related to accuracy, portability, and cost-effectiveness are expected to
be high impact rendering drivers for the market
- Growing awareness and
increasing dependency of healthcare practitioners on the usage of
point-of-care diagnostic enabled medical devices and consumables are
expected to drive the IVD infectious diseases market growth over the
forecast period
- Key applications of
immunochemistry include detection of infectious microorganisms such as
virus, bacteria, and fungus and their toxins and coat antigens
- Development of techniques
such as Polymerase Chain Reaction (PCR) and in-situ hybridization is
expected to boost the molecular diagnostics segment over the forecast
period
- Key players include
bioMérieux SA; BD; Abbott; Quidel Corporation; F. Hoffmann-La Roche Ltd.;
Alere Inc.; Cepheid; Hologic Inc.; Qiagen N.V.; Orasure Technologies,
Inc.; Bio-Rad Laboratories, Inc.; and Siemens Healthcare GmbH.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/ivd-infectious-disease-market/request/rs1
Grand View Research has segmented
the global IVD infectious diseases market based on product, technology,
application, end use, and region:
IVD Infectious
Diseases Product Outlook (Revenue, USD Million, 2015 - 2027)
- Instruments
- Reagents
- Software
IVD Infectious
Diseases Technology Outlook (Revenue, USD Million, 2015 - 2027)
- Immunochemistry
- Molecular Diagnostics
- Microbiology
- Others
IVD Infectious
Diseases Application Outlook (Revenue, USD Million, 2015 - 2027)
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- TB and Drug-resistant TB
- Gastro-intestinal Panel
Testing
- Chlamydia
- Gonorrhea
- HPV
- HIV
- Hepatitis C
- Hepatitis B
- Others
IVD Infectious
Diseases End-use Outlook (Revenue, USD Million, 2015 - 2027)
- Point of Care
- Central Laboratories
IVD Infectious
Diseases Regional Outlook (Revenue, USD Million, 2015 - 2027)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- France
- Italy
- Latin America
- Brazil
- Mexico
- Argentina
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment